sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
24-Apr-2014 12:58
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Portal: Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 826-850 out of 885.

<< < 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 > >>

Public Release: 31-May-2012
Hepatology
Prevalence of chronic hepatitis B may exceed 2 million, higher in US than previously reported
The prevalence of chronic hepatitis B virus (HBV) infection in the US may be as high as 2.2 million cases according to a new study now available in Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases. Findings suggest the higher prevalence of chronic HBV can be attributed to foreign-born persons who were infected in their country of origin prior to arrival in the US.

Contact: Dawn Peters
healthnews@wiley.com
781-388-8408
Wiley

Public Release: 31-May-2012
Physics to tackle how food is cooked in future
In this month's Physics World, Sidney Perkowitz, Candler Professor of Physics Emeritus at Emory University, explains how applied physics led to the innovation of flameless cooking in the late 19th century and addresses the challenge of feeding a rapidly growing population in a cleaner, more efficient way.

Contact: Michael Bishop
michael.bishop@iop.org
44-117-930-1032
Institute of Physics

Public Release: 31-May-2012
PLOS ONE
Weather patterns can be used to forecast rotavirus outbreaks
By correlating weather factors like temperature, rain, and snowfall, Elena Naumova, Ph.D., professor of civil and environmental engineering at Tufts School of Engineering, is able to predict the timing and intensity of rotavirus, a disease that causes extreme diarrhea, dehydration and thousands of death annually, particularly among children. Her research focused on one of the hardest-hit regions of the world, South Asia.
NIH/National Institute of Environmental Health Sciences, National Institutes of Health, FIC Global Infectious Disease Research Training, others

Contact: Alex Reid
Alexander.Reid@tufts.edu
617-627-4173
Tufts University

Public Release: 30-May-2012
American Journal of Human Biology
Understanding the links between inflammation and chronic disease
American parents may want to rethink how much they protect their children from everyday germs. A new Northwestern University study done in lowland Ecuador finds no evidence of chronic low-grade inflammation -- associated with diseases of aging like cardiovascular disease. In contrast, about one-third of adults in the U.S. have chronically elevated C-reactive protein. Acute elevations in CRP are important for protection against infectious disease. When chronically produced, CRP is associated with chronic diseases.

Contact: Hilary Hurd Anyaso
h-anyaso@northwestern.edu
847-491-4887
Northwestern University

Public Release: 30-May-2012
MIT-designed cooler preserves tuberculosis drugs, records doses
A simple cooler could help patients battle antibiotic-resistant tuberculosis.

Contact: Caroline McCall
cmccall5@mit.edu
Massachusetts Institute of Technology

Public Release: 29-May-2012
Proceedings of the National Academy of Sciences
50-year cholera mystery solved
For 50 years scientists have been unsure how the bacteria that gives humans cholera manages to resist one of our basic innate immune responses. That mystery has now been solved, thanks to research from biologists at the University of Texas at Austin.
National Institutes of Health, National Science Foundation, Welch Foundation

Contact: Stephen Trent
strent@mail.utexas.edu
512-232-8371
University of Texas at Austin

Public Release: 29-May-2012
PLOS Medicine
New approach to screen pregnant women for mental health disorders
A new model of care for screening and treating women around the time of childbirth for mental health disorders shows promise according to researchers from South Africa reporting in this week's PLoS Medicine as part of the newly launched series in global mental health practice.

Contact: Clare Weaver
press@plos.org
44-122-344-2834
PLOS

Public Release: 24-May-2012
Conference on Desalination for the Environment in Barcelona
Ben-Gurion U. researchers successfully test solar desalination system for arid land agriculture
The solar-powered system uses nanofiltration membranes to treat the local brackish water, resulting in high-quality desalinated irrigation water. The results of the Josefowitz Oasis Project indicate that irrigation with desalinated water yields higher productivity from water and inorganic fertilizers compared with current practices. Crops grown with desalinated water required 25 percent less irrigation and fertilizer than brackish water irrigation.
Alliance For Global Good, Samuel Josefowitz

Contact: Andrew Lavin
andrewlavin@alavin.com
516-944-4486
American Associates, Ben-Gurion University of the Negev

Public Release: 23-May-2012
Organic Process Research & Development
New process would make anti-malarial drug less costly
Scientists are reporting development of a new, higher-yield, two-step, less costly process that may ease supply problems and zigzagging prices for the raw material essential for making the mainstay drug for malaria. That disease sickens 300-500 million people annually and kills more than one million. The report on the process, which uses readily available substances and could be easily implemented by drug companies, appears in ACS' journal Organic Process Research & Development.

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society

Public Release: 23-May-2012
Science Translational Medicine
Anti-inflammatory drugs may improve survival from severe malaria
A novel anti-inflammatory drug could help to improve survival in the most severe cases of malaria by preventing the immune system from causing irrevocable brain and tissue damage. Walter and Eliza Hall Institute researchers have shown that a new class of anti-inflammatory agents, called IDR (innate defense regulator) peptides, could help to increase survival from severe clinical malaria when used in combination with antimalarial drugs.
Foundation of the National Institutes of Health and Canadian Institutes for Health Research/Grand Challenges in Global Health Research, National Health and Medical Research Council of Australia, Victorian Government

Contact: Liz Williams
williams@wehi.edu.au
61-405-279-095
Walter and Eliza Hall Institute

Public Release: 22-May-2012
New initiative aims to increase mobility for disabled children worldwide
A team of global partners has tasked itself with the daunting challenge of bringing mobility to disabled children of developing nations through the Lifelong Mobility Project.
The Benter Foundation

Contact: Debbie Morton
dmorton@mercyhurst.edu
814-824-2552
Mercyhurst College

Public Release: 22-May-2012
PLOS ONE
Newly discovered breast milk antibodies help neutralize HIV
Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, and showed that the B cells in breast milk can generate neutralizing antibodies that may inhibit the virus that causes AIDS.
National Institutes of Health, Doris Duke Foundation Clinical Scientist Development Award, Gates Foundation, others

Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center

Public Release: 22-May-2012
UC San Diego Superfund Research Program receives $15 million grant renewal
The National Institute of Environmental Health Sciences, part of the National Institutes of Health, has renewed funding for the Superfund Research Program at the University of California, San Diego. Over the next five years, the $15 million grant will fund continued research on the molecular and genetic consequences of exposure to uncontrolled toxicants from Superfund and other hazardous waste sites.
NIH/National Institute of Environmental Health Sciences

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego

Public Release: 22-May-2012
Dissertations and Features
Better tests for sleeping sickness
Lies Van Nieuwenhove, researcher at the Antwerp Institute of Tropical Medicine, has produced proteins imitating typical parts of the sleeping sickness parasite. They can be used in more efficient diagnostic tests, without the need for culturing dangerous parasites.

Contact: Lies Van Nieuwenhove
lvnieuwenhove@itg.be
32-496-274-434
Institute of Tropical Medicine Antwerp

Public Release: 21-May-2012
Biomedical Optics Express
New microscope uses rainbow of light to image the flow of individual blood cells
Blood tests convey vital medical information, but the sight of a needle often causes anxiety and results take time. A new device developed by a team of researchers in Israel, however, can reveal much the same information as a traditional blood test in real-time, simply by shining a light through the skin. This portable optical instrument is able to provide high-resolution images of blood coursing through veins without the need for harsh fluorescent dyes.

Contact: Angela Stark
astark@osa.org
202-416-1443
The Optical Society

Public Release: 21-May-2012
Sustainable R&D framework needed to address essential health needs of developing countries
The Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, welcomes the experts' conclusion that 'the time has now come for WHO Member States to begin a process leading to the negotiation of a binding agreement on R&D relevant to the health needs of developing countries'.

Contact: Violaine Dallenbach
vdallenbach@dndi.org
41-229-069-247
Drugs for Neglected Diseases Initiative

Public Release: 21-May-2012
Lancet Infectious Diseases
NIH study shows poor quality malaria drugs pose threat
Poor quality antimalarial drugs lead to drug resistance and inadequate treatment that pose an urgent threat to vulnerable populations, according to a National Institutes of Health study published May 22 in the Lancet Infectious Diseases journal. Emergence of malaria strains that are resistant to artemisinin drugs on the Thailand-Cambodia border make it imperative to improve the drug supply, stressed the authors.
NIH/Fogarty International Center, National Institutes of Health

Contact: Ann Puderbaugh
ann.puderbaugh@nih.gov
NIH/Fogarty International Center

Public Release: 20-May-2012
Nature Medicine
Drug found for parasite that is major cause of death worldwide
Research by a collaborative group of scientists from UC San Diego School of Medicine, UC San Francisco and Wake Forest School of Medicine has led to identification of an existing drug that is effective against Entamoeba histolytica. This parasite causes amebic dysentery and liver abscesses and results in the death of more than 70,000 people worldwide each year.
Sandler Foundation, NIH/National Institute of Allergy and Infectious Diseases

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego

Public Release: 20-May-2012
Nature Medicine
Lab tests show arthritis drug effective against global parasite
A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world.
Sandler Foundation, NIH/National Institute of Allergy and Infectious Diseases

Contact: Kristen Bole
kristen.bole@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 17-May-2012
Science
'Rare' genetic variants are surprisingly common, life scientists report
A large survey of human genetic variation, published today in the online version of the journal Science, shows that rare genetic variants are not so rare after all, and offers insights into human diseases. A team of scientists studied 202 genes in 14,002 people -- one of the largest ever in a sequencing study in humans.

Contact: Stuart Wolpert
swolpert@support.ucla.edu
310-206-0511
University of California - Los Angeles

Public Release: 17-May-2012
International Journal of Computers in Healthcare
Bluetooth baby
Checking the heart of the unborn baby usually involves a stethoscope. However, an inexpensive and accurate Bluetooth fetal heart rate monitoring system has now been developed by researchers in India for long-term home care. Details are reported in a forthcoming issue of the International Journal of Computers in Healthcare.

Contact: Vijay S. Chourasia
chourasiav@gmail.com
91-937-012-0610
Inderscience Publishers

Public Release: 16-May-2012
Nature Medicine
Scientists uncover potential treatment for painful side effect of diabetes
Research published in the journal Nature Medicine reveals that a multinational collaboration between scientists from Warwick Medical School in the UK, and universities in Germany, New York, Australia and Eastern Europe, has discovered key information around one of the most distressing side effects of diabetes.

Contact: Kate Cox
kate.cox@warwick.ac.uk
44-247-657-4255
University of Warwick

Public Release: 16-May-2012
New England Journal of Medicine
In drug-approval race, US FDA ahead of Canada, Europe
The US Food and Drug Administration generally approves drug therapies faster and earlier than its counterparts in Canada and Europe, according to a new study by Yale School of Medicine researchers. The study counters perceptions that the drug approval process in the United States is especially slow.
Pew Charitable Trusts

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University

Public Release: 15-May-2012
JAMA
Considerable prevalence of both malaria, STIs exist among pregnant women in sub-Saharan Africa
A review of studies reporting estimates of the prevalence of sexually transmitted infections/reproductive tract infections (STIs/RTIs) and malaria over the past 20 years suggests that a considerable burden of malaria and STIs/RTIs exists among pregnant women attending antenatal (before birth) facilities in sub-Saharan Africa, according to a review and meta-analysis of previous studies published in the May 16 issue of JAMA, a theme issue on global health.

Contact: Katie Steels
katie.steels@lshtm.ac.uk
The JAMA Network Journals

Public Release: 15-May-2012
GBCHealth Conference introduces MDG Health Alliance
The MDG Health Alliance, an innovative new private sector organization created and led by eminent business leaders to tackle urgent global health problems, was introduced today in the United States at the GBCHealth Conference.

Contact: Eve Heyn
eheyn@gbchealth.org
212-584-1651
Burness Communications

Showing releases 826-850 out of 885.

<< < 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 > >>